Pancreatic cancer
Results
Phase 2
This trial looked at a new combination of chemotherapy with cisplatin and irinotecan for people with advanced pancreatic cancer.
It recruited people who hadn’t had treatment for their cancer before.
Recruitment start: 1 January 2000
Recruitment end: 1 January 2002
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Bass Hassan
Aventis Pharma
Queen Elizabeth Hospital Birmingham
University of Birmingham
Last reviewed: 23 November 2015
CRUK internal database number: 195
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
